tiprankstipranks
Trending News
More News >
4D Molecular Therapeutics (FDMT)
NASDAQ:FDMT
US Market

4D Molecular Therapeutics (FDMT) Revenue

Compare
364 Followers

4D Molecular Therapeutics Revenue

4D Molecular Therapeutics had a revenue of 1.00K in the quarter ending Dec 31, 2024, with -66.67%. This bring the company's revenue in the last twelve months to 37.00K, Decreased 117.65%. In the fiscal year ending Dec 31, 2024, 4D Molecular Therapeutics had annual revenue of 37.00K with -99.82% growth.
Revenue (ttm)
37.00K
Revenue Growth
P/S Ratio
4845.31
Revenue/Employee
$163
Employees
227
Market Cap
$179.28M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
37.00K-20.69M-99.82%
Dec 31, 2023
20.72M17.59M+562.29%
Dec 31, 2022
3.13M-14.91M-82.65%
Dec 31, 2021
18.04M4.43M+32.52%
Dec 31, 2020
13.61M6.63M+94.85%
Dec 31, 2019
6.99M-7.14M-50.56%
Dec 31, 2018
14.13M8.34M+144.04%
Dec 31, 2017
5.79M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis